Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Blue Owl Capital Holdings

Latest statistics and disclosures from Blue Owl Capital Holdings's latest quarterly 13F-HR filing:

Top 5 stock holdings are SPCX, AKTS, CGEM, LRMR, NCDL, and represent 63.29% of Blue Owl Capital Holdings's stock portfolio.
Added to shares of these 10 stocks: SPCX (+$239M), COF (+$24M), Deep Fission Ord (+$15M), ARTV (+$8.5M), DELL (+$8.2M), SGMT (+$7.2M), CMPS (+$6.4M), LRMR (+$6.2M), VRDN, ORIC.
Started 20 new stock positions in Erasca, CHYM, VRDN, ZEOWW, CABA, CELC, MRNO, NVNIW, Engene Therapeutics, SPCX. ARTV, COF, CMPS, LVWR.WS, Stablecoinx, Eledon Pharmaceuticals, Alpha Modus Hldgs, Deep Fission Ord, HELP, VOD.
Reduced shares in these 10 stocks: Engene Holdings (-$30M), MPLT (-$9.9M), CGEM (-$6.7M), CVEO, Kalvista Pharmaceuticals, OVID, RARE, PLRX, ELDN, AKTS.
Sold out of its positions in Vodafone Group, AMOD, Bitcoin Depot In, CAH, DAIC, CVEO, Engene Holdings, ENGNW, EPD, Gohealth Inc Cl A. Kalvista Pharmaceuticals, Katapult Holdings, Mineralys Therapeutics, Olema Pharmaceuticals, OVID, PLRX, Structure Therapeutics, OPTXW, Viking Therapeutics Inc call.
Blue Owl Capital Holdings was a net buyer of stock by $248M.
Blue Owl Capital Holdings has $665M in assets under management (AUM), dropping by 80.92%.
Central Index Key (CIK): 0001858703

Tip: Access up to 7 years of quarterly data

Positions held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Blue Owl Capital Holdings

Blue Owl Capital Holdings holds 76 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Space Exploration Techn Corp Class A Com Stk (SPCX)	36.0	$239M	NEW	1.4M	170.86	View chart
Aktis Oncology (AKTS)	14.9	$99M	-2%	3.1M	32.23	View chart
Cullinan Oncology (CGEM)	4.2	$28M	-19%	1.5M	18.21	View chart
Larimar Therapeutics (LRMR)	4.2	$28M	+28%	9.2M	3.05	View chart
Nuveen Churchill Direct Lend Com Shs (NCDL)	4.0	$27M		2.1M	12.42	View chart
Maplight Therapeutics (MPLT)	3.9	$26M	-27%	730k	35.84	View chart
Capital One Financial (COF)	3.6	$24M	NEW	120k	200.62	View chart
Owl Rock Capital Corporation (OBDC)	3.3	$22M		2.0M	10.87	View chart
Deep Fission Ord	2.2	$15M	NEW	1.3M	11.04	View chart
Dell Technologies CL C (DELL)	2.1	$14M	+137%	33k	431.46	View chart
Holley (HLLY)	1.7	$11M	+3%	4.4M	2.55	View chart
Eyepoint Com New (EYPT)	1.6	$11M	-16%	763k	14.30	View chart
Sagimet Biosciences Com Ser A (SGMT)	1.5	$9.7M	+277%	1.3M	7.73	View chart
Corvus Pharmaceuticals (CRVS)	1.4	$9.1M	+11%	609k	14.94	View chart
Artiva Biotherapeutics (ARTV)	1.3	$8.5M	NEW	875k	9.70	View chart
Compass Therapeutics (CMPX)	1.2	$7.9M	+23%	3.6M	2.19	View chart
Conduent Incorporate (CNDT)	1.1	$7.4M		5.0M	1.46	View chart
Rhythm Pharmaceuticals (RYTM)	1.0	$6.8M		62k	111.03	View chart
Compass Pathways Sponsored Ads (CMPS)	1.0	$6.4M	NEW	450k	14.15	View chart
Ultragenyx Pharmaceutical (RARE)	0.9	$6.1M	-39%	183k	33.39	View chart
Palvella Therapeutics Inc Ne (PVLA)	0.8	$5.5M	+15%	36k	152.82	View chart
Imagenebio (IMA)	0.8	$5.4M	-4%	918k	5.90	View chart
Compass Pathways Call Call Option	0.8	$5.2M	-7%	1.7M	3.10	View chart
Miragen Therapeutics (VRDN)	0.7	$4.8M	NEW	260k	18.37	View chart
Immix Biopharma (IMMX)	0.7	$4.5M	-20%	438k	10.31	View chart
Oric Pharmaceuticals (ORIC)	0.7	$4.3M	+166%	400k	10.83	View chart
Lenz Therapeutics (LENZ)	0.6	$4.3M	+49%	757k	5.68	View chart
Aquestive Therapeutics (AQST)	0.6	$3.9M	-30%	943k	4.16	View chart
Starwood Property Trust (STWD)	0.5	$3.2M	+23%	196k	16.38	View chart
Evommune Com Shs (EVMN)	0.4	$2.4M	+80%	180k	13.29	View chart
Eledon Pharmaceuticals (ELDN)	0.3	$2.2M	-60%	567k	3.94	View chart
Cabaletta Bio (CABA)	0.3	$2.2M	NEW	715k	3.11	View chart
Chime Finl Com Shs Cl A (CHYM)	0.3	$1.8M	NEW	90k	20.48	View chart
Context Therapeutics (CNTX)	0.2	$1.6M	-42%	2.9M	0.55	View chart
Ww Intl (WW)	0.2	$1.3M	-11%	84k	15.98	View chart
Marker Therapeutics Com New (MRKR)	0.1	$815k		554k	1.47	View chart
Erasca Call Call Option	0.1	$795k	NEW	100k	7.95	View chart
Adc Therapeutics Sa SHS (ADCT)	0.1	$785k		734k	1.07	View chart
Cybin Com New (HELP)	0.1	$396k	NEW	60k	6.61	View chart
Fold Hldgs Com Cl A (FLD)	0.1	$386k		857k	0.45	View chart
Niocorp Devs *w Exp 03/17/202 (NIOBW)	0.1	$381k	-16%	268k	1.42	View chart
Eledon Pharmaceuticals Call Call Option	0.0	$285k	NEW	200k	1.43	View chart
Rezolve Ai *w Exp 08/15/202 (RZLVW)	0.0	$214k		235k	0.91	View chart
Brand Engagement Network *w Exp 03/14/202 (BNAIW)	0.0	$204k	-12%	1.5M	0.14	View chart
Piper Sandler Companies Com New (PIPR)	0.0	$176k		2.4k	72.34	View chart
Engene Therapeutics *w Exp 10/31/202	0.0	$148k	NEW	511k	0.29	View chart
Larimar Therapeutics Call Call Option	0.0	$146k	-25%	729k	0.20	View chart
Celcuity (CELC)	0.0	$131k	NEW	1.2k	104.62	View chart
Compass Therapeutics Call Call Option	0.0	$106k	-24%	304k	0.35	View chart
Stablecoinx *w Exp 06/25/203	0.0	$103k	NEW	250k	0.41	View chart
Energy Transfer Com Ut Ltd Ptn (ET)	0.0	$102k		5.3k	19.12	View chart
Caris Life Sciences (CAI)	0.0	$84k		4.7k	17.82	View chart
Vodafone Group Sponsored Adr (VOD)	0.0	$71k	NEW	5.4k	13.22	View chart
Dave *w Exp 01/05/202 (DAVEW)	0.0	$68k		29k	2.38	View chart
Murano Global Invt SHS (MRNO)	0.0	$63k	NEW	262k	0.24	View chart
Alpha Modus Hldgs *w Exp 12/13/202 (AMODW)	0.0	$56k		1.9M	0.03	View chart
Roadzen *w Exp 11/30/202 (RDZNW)	0.0	$43k		225k	0.19	View chart
Alpha Modus Hldgs Cl A New	0.0	$42k	NEW	9.9k	4.26	View chart
Aeon Biopharma Cl A New (AEON)	0.0	$31k		42k	0.72	View chart
Southland Hldgs *w Exp 02/14/202 (SLND.WS)	0.0	$26k		860k	0.03	View chart
Blue Gold *w Exp 04/01/203 (BGLWW)	0.0	$21k		175k	0.12	View chart
Shf Holdings Cl A New (SHFS)	0.0	$18k		76k	0.24	View chart
Blacksky Technology *w Exp 09/09/202 (BKSY.WS)	0.0	$18k		350k	0.05	View chart
Tevogen Bio Hldgs *w Exp 02/14/202 (TVGNW)	0.0	$12k		200k	0.06	View chart
Zeo Energy Corp *w Exp 03/13/202 (ZEOWW)	0.0	$10k	NEW	250k	0.04	View chart
Livewire Group *w Exp 09/26/202 (LVWR.WS)	0.0	$8.0k	NEW	400k	0.02	View chart
Nvni Group *w Exp 11/01/202 (NVNIW)	0.0	$6.0k	NEW	200k	0.03	View chart
Katapult Holdings Com New (KPLT)	0.0	$5.4k		5.4k	0.99	View chart
Cid Holdco *w Exp 12/31/202 (DAICW)	0.0	$4.4k		445k	0.01	View chart
Baird Med Invt Hldgs *w Exp 10/01/202 (BDMDW)	0.0	$4.0k		100k	0.04	View chart
Pagaya Technologies *w Exp 99/99/999 (PGYWW)	0.0	$2.4k		49k	0.05	View chart
Stardust Pwr *w Exp 06/21/202 (SDSTW)	0.0	$2.2k		17k	0.13	View chart
Liminatus Pharma *w Exp 04/30/203 (LIMNW)	0.0	$2.0k		50k	0.04	View chart
Waldencast *w Exp 07/27/202 (WALDW)	0.0	$1.7k		33k	0.05	View chart
Xbp Global Holdings *w Exp 11/30/202 (XBPEW)	0.0	$1.5k		25k	0.06	View chart
Aspire Biopharma Hldgs *w Exp 02/14/203 (ASBPW)	0.0	$1.0k		50k	0.02	View chart

Past Filings by Blue Owl Capital Holdings

SEC 13F filings are viewable for Blue Owl Capital Holdings going back to 2021

Blue Owl Capital Holdings 2026 Q2 filed Aug. 11, 2026
Blue Owl Capital Holdings 2026 Q1 filed May 14, 2026
Blue Owl Capital Holdings 2025 Q4 restated filed Feb. 20, 2026
Blue Owl Capital Holdings 2025 Q3 filed Nov. 12, 2025
Blue Owl Capital Holdings 2025 Q2 filed Aug. 11, 2025
Blue Owl Capital Holdings 2025 Q1 filed May 15, 2025
Blue Owl Capital Holdings 2024 Q4 filed Feb. 14, 2025
Blue Owl Capital Holdings 2024 Q3 filed Nov. 14, 2024
Blue Owl Capital Holdings 2024 Q2 filed Aug. 15, 2024
Blue Owl Capital Holdings 2024 Q1 filed May 15, 2024
Blue Owl Capital Holdings 2023 Q4 filed Feb. 15, 2024
Blue Owl Capital Holdings 2023 Q3 filed Nov. 14, 2023
Blue Owl Capital Holdings 2023 Q2 filed Aug. 11, 2023
Blue Owl Capital Holdings 2023 Q1 filed May 11, 2023
Blue Owl Capital Holdings 2022 Q4 filed Feb. 13, 2023
Blue Owl Capital Holdings 2022 Q3 filed Nov. 14, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z